← All trials
NCT05490134
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2023
- Primary completion
- Jan 1, 2027
- Completion date
- Oct 1, 2027
- First posted
- Aug 5, 2022
- Last posted
- Nov 8, 2022
- Enrollment
- 136
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Medical University of South CarolinaLead sponsor
- Medical University of South CarolinaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.